US 11001641
Monoclonal antibody therapy for pancreas cancer
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 11001641 (Monoclonal antibody therapy for pancreas cancer) held by PRECISION BIOLOGICS, INC. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/6859, A61K49/04